AHL Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-5,696
Closed -$404K 1165
2016
Q3
$404K Buy
+5,696
New +$404K 0.02% 887